Read more
13:55 · 29 July 2024

Top stock reports to watch this week (29.07.2024)

The week ahead is full of top-tier macro events, like release of US jobs data or rate decision from Fed, Bank of Japan or Bank of England. However, the earnings calendar for the week ahead is also packed with release from top-tier US companies, including a number of Big Tech stocks. Among this week's earnings highlights, one can find:

  • Advanced Micro Devices (AMD.US) - Tuesday
  • Microsoft (MSFT.US) - Tuesday
  • Arm Holdings (ARM.US) - Wednesday
  • Meta Platforms (META.US) - Wednesday
  • Qualcomm (QCOM.US) - Wednesday
  • Apple (AAPL.US) - Thursday
  • Amazon (AMZN.US) - Thursday
  • Intel (INTC.US) - Thursday

While the list of highlighted stocks may suggest that this week's calendar will only include tech shares, this is not the case. Investors will be offered financials from companies from all across the US economy, including a total of 9 Dow Jones members - McDonald's, Microsoft, Procter & Gamble, Merck & Co, Boeing, Amazon, Apple, Intel and Chevron.

Top Wall Street earnings reports scheduled for this week. Source: Bloomberg Finance LP, XTB Research

15 May 2026, 15:27

Market Wrap: Stocks and metals dip as Trump-Xi summit fails to break Iran deadlock 📉 (15.05.2026)

14 May 2026, 22:00

Daily Summary: Market euphoria shows no signs of letting up 🚀

14 May 2026, 21:02

Will OpenAI launch a legal battle against Apple❓�

14 May 2026, 17:50

US OPEN: Cisco shares surge; markets open higher ⏰

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.